Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $292.50 million. The enterprise value is $178.66 million.
Important Dates
The next estimated earnings date is Thursday, March 19, 2026, before market open.
| Earnings Date | Mar 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 18.51 million shares outstanding. The number of shares has increased by 450.90% in one year.
| Current Share Class | 18.51M |
| Shares Outstanding | 18.51M |
| Shares Change (YoY) | +450.90% |
| Shares Change (QoQ) | +29.28% |
| Owned by Insiders (%) | 3.46% |
| Owned by Institutions (%) | 50.09% |
| Float | 10.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,508.98 |
| Forward PS | n/a |
| PB Ratio | 3.05 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 930.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.28 |
| Quick Ratio | 14.00 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -174.79% and return on invested capital (ROIC) is -6,834.62%.
| Return on Equity (ROE) | -174.79% |
| Return on Assets (ROA) | -37.18% |
| Return on Invested Capital (ROIC) | -6,834.62% |
| Return on Capital Employed (ROCE) | -56.77% |
| Weighted Average Cost of Capital (WACC) | 8.93% |
| Revenue Per Employee | $8,348 |
| Profits Per Employee | -$4.33M |
| Employee Count | 23 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $149,000 in taxes.
| Income Tax | 149,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +107.56% in the last 52 weeks. The beta is 0.85, so AVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +107.56% |
| 50-Day Moving Average | 17.43 |
| 200-Day Moving Average | 10.71 |
| Relative Strength Index (RSI) | 42.66 |
| Average Volume (20 Days) | 261,735 |
Short Selling Information
The latest short interest is 2.57 million, so 13.88% of the outstanding shares have been sold short.
| Short Interest | 2.57M |
| Short Previous Month | 1.86M |
| Short % of Shares Out | 13.88% |
| Short % of Float | 23.68% |
| Short Ratio (days to cover) | 7.79 |
Income Statement
In the last 12 months, AVTX had revenue of $192,000 and -$99.70 million in losses. Loss per share was -$8.74.
| Revenue | 192,000 |
| Gross Profit | -31.91M |
| Operating Income | -66.49M |
| Pretax Income | -99.73M |
| Net Income | -99.70M |
| EBITDA | -66.10M |
| EBIT | -66.49M |
| Loss Per Share | -$8.74 |
Full Income StatementBalance Sheet
The company has $111.62 million in cash and $555,000 in debt, with a net cash position of $111.06 million or $6.00 per share.
| Cash & Cash Equivalents | 111.62M |
| Total Debt | 555,000 |
| Net Cash | 111.06M |
| Net Cash Per Share | $6.00 |
| Equity (Book Value) | 91.55M |
| Book Value Per Share | 5.14 |
| Working Capital | 105.87M |
Full Balance SheetCash Flow
| Operating Cash Flow | -52.26M |
| Capital Expenditures | n/a |
| Free Cash Flow | -52.26M |
| FCF Per Share | -$2.82 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -34,632.29% |
| Pretax Margin | -51,942.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -450.90% |
| Shareholder Yield | -450.90% |
| Earnings Yield | -34.41% |
| FCF Yield | -18.04% |
Analyst Forecast
The average price target for AVTX is $32.29, which is 104.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.29 |
| Price Target Difference | 104.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 150.40% |
| EPS Growth Forecast (5Y) | -34.92% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
AVTX has an Altman Z-Score of -4.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.05 |
| Piotroski F-Score | 2 |
